| Attribute |
Value |
| 52 Week Change |
1.003582 |
| Address1 |
12,100 West Sixth Avenue |
| All Time High |
333.42 |
| All Time Low |
0.25 |
| Ask |
164.19 |
| Ask Size |
2 |
| Audit Risk |
8 |
| Average Analyst Rating |
2.3 - Buy |
| Average Daily Volume10 Day |
163,700 |
| Average Daily Volume3 Month |
195,217 |
| Average Volume |
195,217 |
| Average Volume10Days |
163,700 |
| Beta |
0.93 |
| Bid |
91.78 |
| Bid Size |
2 |
| Board Risk |
4 |
| Book Value |
33.71 |
| City |
Lakewood |
| Compensation As Of Epoch Date |
1,798,675,200 |
| Compensation Risk |
2 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
129.09 |
| Current Ratio |
1.794 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,786,665,600 |
| Day High |
129.66 |
| Day Low |
126.79 |
| Debt To Equity |
85.479 |
| Display Name |
Mesa Laboratories |
| Dividend Date |
1,789,430,400 |
| Dividend Rate |
0.64 |
| Dividend Yield |
0.5 |
| Earnings Call Timestamp End |
1,786,393,800 |
| Earnings Call Timestamp Start |
1,786,393,800 |
| Earnings Growth |
-0.424 |
| Earnings Quarterly Growth |
-0.403 |
| Earnings Timestamp |
1,786,392,000 |
| Earnings Timestamp End |
1,793,908,800 |
| Earnings Timestamp Start |
1,793,908,800 |
| Ebitda |
45,437,000 |
| Ebitda Margins |
0.18195 |
| Enterprise To Ebitda |
18.74 |
| Enterprise To Revenue |
3.41 |
| Enterprise Value |
851,484,736 |
| Eps Current Year |
9.95 |
| Eps Forward |
10.27 |
| Eps Trailing Twelve Months |
0.85 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,788,134,400 |
| Exchange |
NMS |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
103.5402 |
| Fifty Day Average Change |
25.549797 |
| Fifty Day Average Change Percent |
0.2467621 |
| Fifty Two Week Change Percent |
100.3582 |
| Fifty Two Week High |
129.66 |
| Fifty Two Week High Change |
-0.5700073 |
| Fifty Two Week High Change Percent |
-0.0043961694 |
| Fifty Two Week Low |
58.83 |
| Fifty Two Week Low Change |
70.259995 |
| Fifty Two Week Low Change Percent |
1.1942885 |
| Fifty Two Week Range |
58.83 - 129.66 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
446,913,000,000 |
| Five Year Avg Dividend Yield |
0.51 |
| Float Shares |
4,945,461 |
| Forward Eps |
10.27 |
| Forward P E |
12.569619 |
| Free Cashflow |
53,380,124 |
| Full Exchange Name |
NasdaqGS |
| Full Time Employees |
717 |
| Fullday Change |
0.440002 |
| Fullday Change Percent |
0.342015 |
| Fullday Price |
126.67 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,785,542,400 |
| Gross Margins |
0.64208 |
| Gross Profits |
160,343,008 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.056199998 |
| Held Percent Institutions |
0.96128 |
| Implied Shares Outstanding |
5,595,869 |
| Industry |
Scientific & Technical Instruments |
| Industry Disp |
Scientific & Technical Instruments |
| Industry Key |
scientific-technical-instruments |
| Ir Website |
http://www.mesalabs.com/corporate/investor.html |
| Is Earnings Date Estimate |
0 |
| Language |
en-US |
| Last Dividend Date |
1,780,012,800 |
| Last Dividend Value |
0.16 |
| Last Fiscal Year End |
1,774,915,200 |
| Long Business Summary |
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado. |
| Long Name |
Mesa Laboratories, Inc. |
| Market |
us_market |
| Market Cap |
722,370,688 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_287550 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
4,800,000 |
| Next Fiscal Year End |
1,806,451,200 |
| Non Diluted Market Cap |
721,867,101 |
| Number Of Analyst Opinions |
2 |
| Open |
127.81 |
| Operating Cashflow |
55,674,000 |
| Operating Margins |
0.11691 |
| Overall Risk |
3 |
| Payout Ratio |
0.7529 |
| Phone |
303 987 8000 |
| Post Market Change |
-2.4199982 |
| Post Market Change Percent |
-1.8746598 |
| Post Market Price |
126.67 |
| Post Market Time |
1,787,960,445 |
| Previous Close |
128.65 |
| Price Eps Current Year |
12.973869 |
| Price Hint |
2 |
| Price To Book |
3.8294275 |
| Price To Sales Trailing12 Months |
2.8926647 |
| Profit Margins |
0.01922 |
| Quick Ratio |
1.163 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
buy |
| Recommendation Mean |
2.33333 |
| Region |
US |
| Regular Market Change |
0.440002 |
| Regular Market Change Percent |
0.342015 |
| Regular Market Day High |
129.66 |
| Regular Market Day Low |
126.79 |
| Regular Market Day Range |
126.79 - 129.66 |
| Regular Market Open |
127.81 |
| Regular Market Previous Close |
128.65 |
| Regular Market Price |
129.09 |
| Regular Market Time |
1,787,947,201 |
| Regular Market Volume |
153,074 |
| Return On Assets |
0.03286 |
| Return On Equity |
0.02657 |
| Revenue Growth |
0.01 |
| Revenue Per Share |
44.898 |
| Sand P52 Week Change |
0.20504117 |
| Sector |
Technology |
| Sector Disp |
Technology |
| Sector Key |
technology |
| Share Holder Rights Risk |
3 |
| Shares Outstanding |
5,595,869 |
| Shares Percent Shares Out |
0.060399998 |
| Shares Short |
337,738 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
274,176 |
| Short Name |
Mesa Laboratories, Inc. |
| Short Percent Of Float |
0.0874 |
| Short Ratio |
2.2 |
| Source Interval |
15 |
| State |
CO |
| Symbol |
MLAB |
| Target High Price |
125.0 |
| Target Low Price |
110.0 |
| Target Mean Price |
117.5 |
| Target Median Price |
117.5 |
| Total Cash |
32,237,000 |
| Total Cash Per Share |
5.761 |
| Total Debt |
161,351,008 |
| Total Revenue |
249,724,992 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.64 |
| Trailing Annual Dividend Yield |
0.0049747378 |
| Trailing Eps |
0.85 |
| Trailing P E |
151.87057 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
93.03075 |
| Two Hundred Day Average Change |
36.05925 |
| Two Hundred Day Average Change Percent |
0.38760573 |
| Type Disp |
Equity |
| Volume |
153,074 |
| Website |
https://www.mesalabs.com |
| Zip |
80,228 |